I had my aortic valve replaced with a mechanicel valve 3 years ago and have since been on warfarin, it all started well but over the last 3 months my INR has become very erratic and I'm now taking warfarin and injecting tinsiparin, I have an appointment with my GP tomorrow and I'm going to ask about self testing is there any help or advice you can give, I have AXAPPP insurance.
Warfarin is an anticoagulant that has been successfully used in the UK for many years.
It is used in many conditions where there is a high risk of blood clot so it is used to prevent these clots from occurring. Deep Vien thrombosis, Pulmonary embolism, Atrial fibrillation and heart valve replacements are just a few such condition.
Warfarin stops the action of Vitamin K. When you have a cut the body plugs the cut with a clot. When the blood starts to clot it sets into action a series of complex chain of protein changes into motion, bit like a domino effect. These blood proteins are known as coagulation factors. They are mainly made in the liver and they require vitamin K for these changes to occur. Warfarin blocks the action of vitamin K in the liver so decreases the tendency to form clots. It acts to prolong the bleeding time also known the prothrombin time.
Warfarin prevents existing clots getting bigger and new clots from forming thereby preventing strokes, heart attacks and clot in the lungs.
Of course uncontrolled bleeding can be fatal so the amount of anticoagulation that is required needs to be monitored carefully. The intensity of anticoagulation is expressed as INR.
INR is an abbreviation of the International Normalised Ratio. INR is a measure of how long it takes a given amount of blood to clot for a person who is taking Warfarin compared to how long it takes for the same amount of blood of an average person who is not on warfarin. If your INR is 3 then it takes three times as long for your blood to clot then an average person.
In other words INR is the prothrombin time expressed as a ratio of the clotting time for patient plasma divided by the clotting time for control plasma corrected by a standardising factor. The higher the INR the greater the risk of bleeding. If the INR of a person who is on Warfarin is too low then the greater the chance of a clot forming. This is why it is important for a person on Warfarin to be within the target INR limits.
If your INR is lower than required the clinic may increase your dose of warfarin and monitor your INR more closely. If it is very high then you may be given vitamin K to bring it down.Again your INR will be closely monitored.
Why are my INR readings erractic?
Vegetables such as spinach, broccoli, Brussel sprouts, avocado and other vegetables and fruits such as berries figs have a large amount of vitamin K. If you keep drastically changing the amount of these vegetables you eat you will vary the amount of vitamin K that is in your body. Since Warfarin blocks the action of vitamin K you will need different amount of Warfarin to cope with the changing amount of vitamin K in your body. Therefore if you keep to the same amount of vegetables everyday you will have a stable INR.
You can drink alcohol whilst you are on Warfarin as long as you drink in moderation and keep to within the limits set by the NHS. They recommend 14units per week for men and women.
Some medications including some antibiotics can affect your INR causing it to go up or down. Your anticoagulation booklet with tell you that you cannot take Non-Steroidal anti-inflammatory NSAIDs such as Ibuprofen so you know you should not have these. However, what you may not be aware of that sometimes Paracetamol can also affect your INR so always check with your pharmacist. If you are on any new medication inform your pharmacist, doctor or healthcare professional at the anticoagulant clinic.
Ginko biloba may increase your risk of bleeding. St John's Wort, ginseng and garlic tablets may reduce blood levels of warfarin. Before you start taking any herbal supplement or any over the counter medicines or supplements always check with your pharmacist or doctor or healthcare professional.
If you are partaking in any of the above factors than this could account for your erratic INR results.
Tinzaparin is low molecular weight heparin LMWH. LMWH are injections that vary in strength like other medicines the dose is specific to each patient based on their weight and requirement.
LMWH enhance the effect of certain coagulation factors thereby prevent clots. They are given by injection into fat usually in the tummy once or twice daily. Tinzaparin may lower platelets so it is not given on a long-term basis.
All LMWH are derived from pork. People who cannot use pork derived products due to religious reasons will need alternative anticoagulant called Fondaparinux.
Recently Dabagatrin, Rivaroxaban, Apixaban and Endoxaban have been introduced as alternatives to Warfarin. They are also known collectively as NOACs. However they are not licensed to be used to prevents clots if you have mechanical valves.
We think you should wait and see what your doctor has to say tomorrow. Please do not hesitate to contact us if you need further information.


Steve's Warriors began in 2017 in honor of a wonderful man, Steve Langkau. Steve lived with type 1 diabetes for over 60 years. After many years of being chronically ill, Steve passed away in February of 2017. While he was still healthy enough, Steve's favorite hobby was bike riding. Not only did he ride and race himself, he loved passing down his hobby to family and friends.
In June 2017, family and friends came together to ride and raise money in Steve's honor at the Saratoga Tour de Cure for the first time. This year, we come together again for the third time to honor the same man, however with bigger goals and aspirations. With the help of our community, we raised $4,800 last year in Steve's name for diabetic research. We are excited to ride for him and raise money and awareness of a cause that affected him and his family so closely. We cannot think of a better way to keep his memory alive and well.
Thank you in advanced to all of those who will help us reach our fundraising goal. Every donation makes such a big difference. The money we raise for the Association funds critical diabetes research, information programs, and advocacy efforts that support the nearly 30 million children and adults in the U.S. with diabetes, and the 86 million with pre-diabetes.


The drumbeat for outcomes-based contracting continues to grow. Most believe the transformation for pharmaceutical manufacturers is now unavoidable. While the signs are everywhere, changing your organization to fit is very difficult.
Our Gap Analysis help to reduce the risk and smooth the transition from a brand-centric organization to one that puts patients in the center. We'll help you identify the gaps in the types of people you employ, your strategy, structure, technology, and values.
> A final meeting with your executives and our senior analysts to understand results, significant gaps and next steps.
It is fast and easy to get started below.


but compares the traits or developments across a wide area of geography or a wide number of disciplines. God can work through the jumbled mess of human history. We test all our parts and remove the bad ones from our production line, of course. Those believing in Me will never thirst." He repeats it in John 14: 6, "Jesus told him, 'I am the Way, the Truth, and the Life. In general, the Dosbarth Gwynedd are considered the standard or "authentic" verse tradition, even though most modern Welsh poets tend to ignore this incredibly complex tradition and concentrate on smaller, simpler forms like the cywydd and the englyn. ) drama : A composition in prose or verse presenting, in pantomime and dialogue, a narrative involving conflict between a character or characters and some external or internal force (see conflict ). The arising of life on earth is indeed a miracle, but we don't need to base our faith on a flawed mathematical analysis. The dangerous idea that life is a story.
Thus absolute meaning continuously and endlessly remains one step removed from the system of signs/words/symbols we use to discuss meaning. Smith, Richard Upsher,. I think there is truth in both statements. Yet his name is familiar to only the most avid followers of horse racing.
New York: Charles. A difficult story can powerfully alter not only he who tells it but also they who hear. The mysterious circumstances of his death have captivated generations writing a sponsorship proposal for under armory of true-crime fanatics. The Autobiographical Fallacy in Chaucer and Langland Studies. This is a strong case, but it is not the only reasonable possibility. You will have plenty of Christian company in your beliefs, too.


Sell your currently owned fleet to us, and we lease it back to you for a fixed monthly installment.
A special form of lease is the Sale & Lease Back in which the car fleet that was already acquired by the customer is sold to Business Lease.
• We arrange everything for you: car registration; maintenance and repairs; tires acquisition, change and storage; fuel card; road assistance; replacement car; insurances; road tax, pick-up and delivery; car wash, on-line reporting.
Would you like to know how you can benefit from Telematics?
Please feel free to contact our sales team – consisting of Anca Vlada and Silviu Zopotila – for more information, a calculation or to schedule an appointment!


text:
Iran says foiled several bids by Israel through 'successful ops' in recent months
Iran Press TV
Wednesday, 27 July 2022 1:48 PM
Iran's Intelligence Ministry says it carried out "a number of successful operations" against Israel in recent months, thwarting vicious conspiracies hatched by the occupying Tel Aviv regime and its allied anti-Iran terrorist groups.
Intelligence Minister Esmail Khatib made the remakes during a meeting between a group of senior legal officials from his ministry and Iran's Parliament Speaker Mohammad Baqer Qalibaf in the capital Tehran on Wednesday.
Khatib noted that the operations "signify the security power" wielded by the country's Intelligence Ministry.
He went on to emphasize that enemies have failed in their attempts to undermine security in Iran.
One of the reasons for their failure is people's cooperation with the intelligence ministry and the incumbent administration towards ensuring sustainable security in the country, Khatib pointed out.
He underscored that his ministry is duty-bound "to fight against terrorism, the Zionist regime, and the acts of sabotage against the country."
In his remarks during the meeting, Qalibaf commended the ministry for playing an effective role in the establishment of security throughout the country, praising Iranian intelligence forces for their achievements.
He stressed that enemies, most notably the United States and Israel, have never stopped targeting Iran's security and stability since the victory of the Islamic Revolution in 1979.
The top Iranian lawmaker also pointed to the ongoing economic pressure campaign against Iran, describing it as a "full-fledged war."
He said the enemy is making constant efforts to undermine the country's various sectors, including the economic ones.
Qalibaf referred to the anti-Iran psychological and media warfare as another instance of the enemy's campaign against Iranians.
"In this war, the enemy is playing out a scenario aimed at shattering the nation's hope, especially that of the youth, and fostering a sense of despair and dejection in them," he asserted.
The top lawmaker called for a comprehensive fight in foiling the psychological and media warfare against Iran, and solving the problems facing the country.
On Saturday, Iran's Intelligence Ministry issued a statement, saying that members of a terrorist group affiliated with Israeli spy agency Mossad were identified and arrested by Iranian security forces before they could carry out acts of sabotage.
The ministry added that the terrorists, who were in contact with Mossad agents through one of the neighboring countries, had sneaked into the country from Iraq's semi-autonomous Kurdistan region.
Nour News website, which is affiliated with Iran's Supreme National Security Council (SNSC), said in its Sunday report that the spy team had marked one of Iran's sensitive facilities in the central province of Isfahan and was planning to blow it up.
The report added that the members of the network were trained in an African country for months and had simulated the aforesaid operation several times.
It also revealed that Iran's security forces were monitoring the spy team even before it arrived in Iran and all its members and contacts both inside and outside the country were identified by the Intelligence Ministry several months before they entered the country.
The spy team had even planted highly explosive substances at the target site and the final phase of their operation was just a few hours away when it was busted, it explained.

redpajama_set_name: RedPajamaCommonCrawl


text:
Tender Edematous Nodules on the Hand
Cutis. 2017 September;100(3):148, 158, 166
Niraj Butala, MD
Steven Manders, MD
Author and Disclosure Information
From Cooper Medical School, Rowan University, Camden, New Jersey.
The authors report no conflict of interest.
Correspondence: Niraj Butala, MD, 3 Cooper Plaza, Ste 504, Camden, NJ 08103 ([email protected]).
A 57-year-old woman presented to the emergency department (ED) for evaluation of a rash on the left hand of 2 weeks' duration. She described pinpoint red lesions on the left palm, as well as the third, fourth, and fifth fingers, which gradually enlarged and became painful. She denied any specific trauma but recalled cutting her hand on a piece of metal in the ground prior to the onset of the rash. She worked on a farm and bottle-fed sheep and chickens. Physical examination revealed tender edematous nodules with central gray pustules, and the left axillary lymph node was enlarged and tender. Ulceration was not appreciated. Various antibiotics including cephalexin, trimethoprim-sulfamethoxazole, and clindamycin were prescribed during prior ED visits, but she reported no improvement with these medications. She remained afebrile throughout the course of the hand rash, and laboratory workup was consistently unremarkable. Two sets of herpes simplex virus cultures from the ED visits showed no growth, and a hand radiograph also was normal. Medical history included coronary artery disease, myocardial infarction, mitral regurgitation, and hyperlipidemia.
What's the diagnosis?
ecthyma contagiosum (orf)
milker's nodule
pyogenic granuloma
The Diagnosis: Ecthyma Contagiosum (Orf)
Orf, or ecthyma contagiosum, is a zoonotic cutaneous infection caused by the orf DNA virus of the genus Parapoxvirus of the family Poxviridae. It is transmitted to humans through direct contact with infected animals, namely sheep and goats, and as such is most commonly seen in patients with occupational exposure to these animals such as butchers, farmers, veterinarians, and shepherds.1,2 Human-to-human transmission is exceedingly rare in immunocompetent patients.2,3 In affected animals, lesions usually are found around the mouth, muzzle, and eyes. In humans, hands are the most commonly affected site, and lesions occur 3 to 10 days after contact. Clinically, the lesions are nonspecific, and our patient presented with tender, erythematous, edematous nodules on the left hand. The differential diagnosis is broad and includes a milker's nodule, pyogenic granuloma, tularemia, anthrax, atypical mycobacterial infection, and sporotrichosis.1,4,5
The diagnosis usually is made with a thorough history and examination, but in cases of uncertainty, routine pathology with hematoxylin and eosin staining, electron microscopy, or real-time polymerase chain reaction may be used.2-4 Histopathologically, lesions demonstrate intraepidermal vesicles, vacuolization of keratinocytes of the upper epidermis with characteristic cytoplasmic inclusion bodies, rete ridge elongation, and dilated vessels in the intervening dermal papillae. Central necrosis may occur in well-developed lesions.2,6 Interestingly, our patient's biopsy exhibited all of these findings (Figure). Immunostains for cytomegalovirus and herpes simplex virus were negative, and Grocott-Gomori methenamine-silver and acid-fast bacillus stains also were negative.
Intraepidermal vesicle with vacuolization of keratinocytes of the upper epidermis (A)(H&E, original magnification ×100) and pale vacuolated keratinocytes with eosinophilic cytoplasmic inclusion bodies (B)(H&E, original magnification ×400).
Our patient also developed lymphangitic streaking suggestive of a bacterial superinfection and was treated with a course of intravenous antibiotics. She eventually was discharged with reassurance, wound care instructions, and outpatient antibiotics. She returned to an outside institution's emergency department for further evaluation, and she was admitted for workup. A lesional swab was sent for real-time polymerase chain reaction, which confirmed the diagnosis as orf. When the patient was contacted for follow-up 1 week after biopsy, the hand lesions had notably improved.
Orf is self-limited and typically resolves within 4 to 8 weeks after undergoing evolution through 5 described stages. The maculopapular stage is denoted by enlarging erythematous macule. The targetoid stage is described by a red center within a white halo surrounded by a broader red halo. The nodular stage is self-descriptive. The regenerative and regression stages describe the progressively improving, drier, and crusted nodules.3
Because orf is self-limited, no treatment is required, and patients should be counseled that their lesions should resolve within weeks. Complications include lymphangitis, secondary bacterial infection, and erythema multiforme.1,2,4,5 Immunocompromised patients may develop recalcitrant, giant, or multiple lesions that may be treated with topical imiquimod, topical cidofovir, intralesional interferon alfa, or surgical excision.1,2,4,7
We present a case of orf to remind practitioners of this rare entity. Although the disease is endemic worldwide, it likely is underreported due to its self-limited nature.2,4 A careful history may reveal the diagnosis, and overtreatment with antibiotics, many of which have their own significant side-effect profile, can then be avoided.
We thank Eric Behling, MD (Camden, New Jersey), for his contributions in obtaining the histologic images.
Veraldi S, Nazzaro G, Vaira F, et al. Presentation of orf (ecthyma contagiosum) after sheep slaughtering for religious feasts. Infection. 2014;42:767-769.
Al-Salam S, Nowotny N, Sohail MR, et al. Ecthyma contagiosum (orf)--report of a human case from the United Arab Emirates and review of the literature. J Cutan Pathol. 2008;35:603-607.
Thurman RJ, Fitch RW. Images in clinical medicine. contagious ecthyma. N Engl J Med. 2015;372:E12.
Meier R, Sommacal A, Stahel A, et al. Orf--an orphan disease? JRSM Open. 2015;6:2054270415593718.
Joseph RH, Haddad FA, Matthews AL, et al. Erythema multiforme after orf virus infection: a report of two cases and literature review. Epidemiol Infect. 2015;143:385-390.
Xu X, Yun SJ, Erikson L, et al. Diseases caused by viruses. In: Elder DE, Elenitsas R, Rosenbach M, eds. Lever's Histopathology of the Skin. 11th ed. Philadelphia, PA: Wolters Kluwer; 2015:781-815.
Koufakis T, Katsaitis P, Gabranis I. Orf disease: a report of a case. Braz J Infect Dis. 2014;18:568-569.
Zika's 2017 summer less active than 2016
Hyperpigmented Patch on the Leg
Amira Elbendary, MBBCh, MSc
Erick J. Dunlop, MD
Patricia Heller, MD
Olga Goulko, MD
Dirk M. Elston, MD
A 32-year-old man presented with an asymptomatic pigmented lesion on the left foot that developed over the course of 4 months. Physical...
Necrotic Ulcer on the Thigh
Timothy J. Hatlen, MD
Richard A. Murphy, MD, MPH
Jon G. Persichino, DO
Bullous Lesions in a Neonate
Thomas F. Byrd IV, MD
Samantha Bapty, MD
Michelle Bardack, MD
A 1-day-old Hispanic female infant was born via uncomplicated vaginal delivery at 41 weeks' gestation after a normal pregnancy. Linear plaques...


On 29 March 2017 WHO launched a global initiative to reduce severe, avoidable medication-associated harm in all countries by 50% over the next 5 years. This so-called "Medication Without Harm" is the 3rd WHO Global Patient Safety Challenge on Medication Safety and involves several IMSN members.
The Global Patient Safety Challenge on Medication Safety aims to address the weaknesses in health systems that lead to medication errors and the severe harm that result. It lays out ways to improve the way medicines are prescribed, distributed and consumed, and increase awareness among patients about the risks associated with the improper use of medication.
Medication errors cause at least one death every day and injure approximately 1.3 million people annually in the United States of America alone. While low- and middle-income countries are estimated to have similar rates of medication-related adverse events to high-income countries, the impact is about twice as much in terms of the number of years of healthy life lost. Many countries lack good data, which will be gathered as part of the initiative. Globally, the cost associated with medication errors has been estimated at US$ 42 billion annually or almost 1% of total global health expenditure.
"We all expect to be helped, not harmed, when we take medication," said Dr Margaret Chan, WHO Director-General. "Apart from the human cost, medication errors place an enormous and unnecessary strain on health budgets. Preventing errors saves money and saves lives."
Every person around the world will at some point in their life take medicines to prevent or treat illness. However, medicines do sometimes cause serious harm if taken incorrectly, monitored insufficiently or as the result of an error, accident or communication problems.
Both health workers and patients can make mistakes that result in severe harm, such as ordering, prescribing, dispensing, preparing, administering or consuming the wrong medication or the wrong dose at the wrong time. But all medication errors are potentially avoidable. Preventing errors and the harm that results requires putting systems and procedures in place to ensure the right patient receives the right medication at the right dose via the right route at the right time.
Medication errors can be caused by health worker fatigue, overcrowding, staff shortages, poor training and the wrong information being given to patients, among other reasons. Any one of these, or a combination, can affect the prescribing, dispensing, consumption, and monitoring of medications, which can result in severe harm, disability and even death. Most harm arises from systems failures in the way care is organized and coordinated, especially when multiple health providers are involved in a patient's care. An organizational culture that routinely implements best practices and that avoids blame when mistakes are made is the best environment for safe care.
The Challenge calls on countries to take early priority action to address these key factors: including medicines with a high risk of harm if used improperly; patients who take multiple medications for different diseases and conditions; and patients going through transitions of care, in order to reduce medication errors and harm to patients.
The actions planned in the Challenge will be focused on four areas: patients and the public; health care professionals; medicines as products; and systems and practices of medication. The Challenge aims to make improvements in each stage of the medication use process including prescribing, dispensing, administering, monitoring and use. WHO aims to provide guidance and develop strategies, plans and tools to ensure that the medication process has the safety of patients at its core, in all health care facilities.
"Over the years, I have spoken to many people who have lost loved ones to medication-related errors," said Sir Liam Donaldson, WHO Envoy for Patient Safety. "Their stories, their quiet dignity and their acceptance of situations that should never have arisen have moved me deeply. It is to the memories of all those who have died due to incidents of unsafe care that this Challenge should be dedicated."
Find out more on the World Health Organization website.
This entry was posted in Uncategorized on March 30, 2017 by Étienne Schmitt.
The International Medication Safety Network (IMSN) recognizes the unsafe naming, labeling and packaging of medicines as an ongoing, often unrecognized worldwide threat to patient safety that requires a collaborative approach. At a recent conference, IMSN called for greater action to standardize safe medication practices and improve medication safety internationally.
Medication errors affect millions of patients around the world, sometimes leading to death or serious harm. But in many instances, more attention needs to be paid to medication errors by regulatory authorities and industry, and the importance of human factors principles in the selection and design of medicine names, labels, and packaging is being overlooked. For example, not all regulators require companies to include bar codes on medication labels, which is essential for use of safety technologies at the bedside, in the operating room, or in the pharmacy. Too often, the issue of errors is being addressed in individual countries, but not on a global scale.
At the IMSN Global Regulatory Meeting: Designing Medication Safety at the Global Level held in Toronto, Canada on October 24, 2016, delegates from 17 member countries shared their views and concerns with invited regulators on factors that contribute to medication errors at a global level. The main regulators involved in this field, such as the US Food and Drug Administration (FDA), Health Canada, the European Medicine Agency (EMA), and the Medicines & Healthcare Products Regulatory Agency (MHRA), were joined by the World Health Organization (WHO) Patient Safety program. A separate session was held with major IV solution and technology companies on October 25, 2016, including Aguettant, Baxter Healthcare, B. Braun, BD/Carefusion, Hospira/Pfizer, Grifols, and Fresenius Kabi.
Recognition of the expertise needed for analysis (including an assessment for contributing factors in preventable adverse drug reactions) and prevention of medication errors, whether by promoting the role of medication safety officers or by encouraging premarket assessment of medicines and associated devices by manufacturers.
Participants agreed that effective bidirectional cooperation between safe practice centers, patient safety organizations and the pharmacovigilance community is needed.
In order to achieve a reduction of harm related to medication errors, harmonization at the global level also is necessary. The IMSN is committed to this harmonization of safe medication practices as they impact packaging and package labeling. Therefore, the IMSN is calling for a follow-up summit with regulatory authorities in order to establish minimum requirements and an action plan for medication safety worldwide.
Beyond product improvement, the IMSN supports the World Health Organization's Global Patient Safety Challenge on Medication Safety, through the participation of several IMSN members. IMSN members are contributing to the WHO initiative to tackle obstacles and propose solutions to improve the safety of medication practices.
This entry was posted in Uncategorized on November 23, 2016 by Étienne Schmitt.


text:
When Treating Cancer Is Not an Option
By JANE E. BRODY
NYTimes.com 620 Eighth Avenue New York, NY 10018
Copyright 2013 The New York Times Company
When my husband learned he had advanced lung cancer, he didn't even want to speak to an oncologist about chemotherapy. He saw no point in treatment that could not cure him and might make him feel worse.
Not so, though, for a majority of patients diagnosed with cancers of the lung or colon that have spread well beyond their original site and are currently not curable by any drugs in the medical armamentarium. Most patients with these so-called stage 4 cancers who choose to undergo chemotherapy seem to believe, incorrectly, that the drugs could render them cancer-free.
That is the finding of a recent national study of nearly 1,200 patients with advanced cancers of the lung or colon. Overall, 69 percent of those with stage 4 lung cancer and 81 percent of those with stage 4 colon cancer failed to understand "that chemotherapy was not at all likely to cure their cancer," Dr. Jane C. Weeks, an oncology researcher at the Dana-Farber Cancer Institute in Boston, and colleagues reported in The New England Journal of Medicine.
When patients do not understand the limitations of such treatment, their consent to undergo it is not truly informed, the authors concluded.
This is not to say that chemotherapy is pointless when cancer is far advanced. Various drugs, some with limited toxicity, can be used as palliatives, perhaps shrinking tumors temporarily to relieve symptoms, slowing the cancer's growth and prolonging the lives of some patients.
But aggressive chemotherapy when death is but weeks or months in the offing can seriously compromise the quality of patients' remaining time and may delay their preparations for the end of life, to the detriment of both patients and their families.
"If you think chemotherapy will cure you, you're less open to end-of-life discussions," Dr. Weeks said in an interview.
When patients pursue chemotherapy under the false belief that they still have a chance for a cure, it often delays their transition to the comfort care of hospice. When patients spend only a few days or a week in hospice, caretakers don't have enough time to get to know them and their families and offer the physical, emotional and practical benefits hospice can provide.
Dr. Weeks said continued chemotherapy involves more trips to the hospital, blood draws and X-rays, whereas hospice attends to patients' symptoms and concerns, and encourages them to leave meaningful legacies. When my husband entered hospice after two miserable weeks in the hospital undergoing palliative radiation, he experienced such relief that he said cheerfully, though in jest, "What if I decide I want to live?" and then enjoyed a treasured last visit with two of his grandchildren.
'Optimistic Bias'
Communication is a two-way street; doctors and patients alike contribute to patients' failure to appreciate medicine's limited ability to treat advanced cancer.
In an editorial accompanying the journal report, Dr. Thomas J. Smith and Dr. Dan L. Longo pointed out that "people have an optimistic bias." Despite a grim prognosis, this bias prompts patients to believe treatment can cure them.
"Even with repeated discussions, about one-third of patients are not able to say they have a disease from which they will die in a year or so," Dr. Smith, an oncologist and director of palliative care at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, said in an interview.
"Our job is not to force them into acceptance but to encourage them to plan for the worst while hoping for the best," Dr. Smith said. "Such patients have better outcomes — less depression and less distress, and they're more likely to die comfortably at home."
Cultural and racial factors, and most likely religious beliefs, influence acceptance of the futility of continued treatment, Dr. Weeks said. In her study, nonwhite and Hispanic patients were more likely than whites to believe that chemotherapy could cure them. But surprisingly, patients' educational level, degree of disability and participation in decision-making were not associated with inaccurate beliefs about chemotherapy.
What can make a huge difference, Dr. Smith said, is how and how often doctors discuss options with patients and describe the potential of continued treatment. He and Dr. Longo suggested that practitioners master "the conversation known as 'ask, tell, ask,' which consists of asking patients what they want to know about their prognosis, telling them what they want to know, and then asking, 'What do you now understand about your situation?' "
Among the questions Dr. Smith said doctors should be asking are, "How much do you want to know about your cancer? What do you know about your cancer? Who would you like to include in discussions about your care? Would you like me to write down the important points? What is important to you? What are you hoping for? Who are your other doctors so that I can communicate with them?"
Continuing Discussion
Finally, he said, rather than asking the patient "do you have any questions?" the doctor should ask, "Now that we have discussed this, what is your understanding of your situation?" And rather than having this conversation only once, Dr. Smith said, "It should be repeated at every transition point."
He and Dr. Longo also recommend that oncologists state the patient's prognosis at the first visit, appoint someone in the office to discuss advance directives, schedule a hospice-information visit, and offer to discuss prognosis and coping at each transition.
Using this approach, practitioners in the US Oncology Network, a group of community-based oncology physicians, have doubled the time patients spend in hospice, decreased costs, alleviated patients' symptoms, reduced stress on caregivers and often lengthened survival, Dr. Smith said. Various studies have shown that cancer patients in hospice live weeks to months longer than comparable patients not in hospice care.
When doctors fail to give direct, clear information, Dr. Smith suggests that patients ask, "What is my prognosis, really? What are my options? Can I meet with the palliative care and hospice teams?"
He noted, "This is the hardest conversation for doctors to have. A lot of doctors wait for someone to bring it up." If the patient does not, then a family member can initiate the needed discussion.


There are pictures of more items posted here also - all the items start at $3.00 and will sell to the highest bidder on Sunday. We sell 1200 items every week from Walmart and Costco and Home Depot and Groupon and Best Buy.
All these great items were Returns--so much great stuff in new and like new condition with $3.00 starting prices! All will sell at whatever price they sell for--no minimums all bids are accepted! LIQUIDATION of goods- but it's all tested and great so buy with CONFIDENCE!!


This week's Throwback Thursday is a historical romance.
1879. In Blue Belle, Montana, everyone knew better than to mess with the Claybornes. The brothers had once been a mismatched gang of street urchins—until they found an abandoned baby girl in a New York city alley, named her Mary Rose, and headed west to raise her to be a lady. They became a family—held together by loyalty and love if not by blood—when suddenly they faced a crisis that threatened to tear them apart….
Trouble came to town with one Lord Harrison Stanford MacDonald. Armed with a swagger and six-shooter, he cut a striking figure—but it soon became apparent to Mary Rose that he was too much of a gentleman to make it in her rough-and-tumble town. She asked her brothers to teach him the basics of frontier survival, which he acquired with ease. And soon he possessed a deep and desperate love for Mary Rose. She returned his affection wholeheartedly… until MacDonald revealed a secret that challenged everything she believed about herself, her life, and her newfound love. Now her search for identity and meaning would begin, raising questions that could only be answered if she listened to the truth within her heart….
How many stars did I give For the Roses when I first read it? 5 stars.
How many stars would I give For the Roses now? 4 stars.
Have you read For the Roses?


"Maybe there's a physicist sitting right beside you, who can explain this better than we do, but we're in the business of art, so we'll make a metaphor," sings Hai-Ting Chinn in Science Fair: An Opera With Experiments. This labor of science-love by the mezzo-soprano involves a hoop skirt doubling as the solar system, a papier-mâché volcano exploding with baking soda and vinegar, and a metaphor that turns the HERE Arts Center theater into the nucleus of an atom, with the audience members as protons.
In the spirit of scientific clarity, Chinn is approaching the piece as a peer-reviewed performance. If you find anything "inaccurate, misleading, or could be better stated in another way," she notes, "please let us know and we will consider revisions for the next version of the show." I happened to have caught a version of the performance when it was in development back in 2014. Through Chinn's years of work on the piece as a HERE Resident Artist, it's blossomed into a 75-minute science demonstration that doesn't waste a lyric in exploring natural phenomena.
Each is presented in Chinn's affecting, operatic voice, along with visual demonstrations. Chinn is probably best known for her captivating performance of Philip Glass's wordless aria in the recent revival of Einstein on the Beach, although science has long been a passion, including her co-hosting of the Scopes Monkey Choir podcast on science and music.
Yet Chinn imbues everything — from a live experiment extracting DNA from a strawberry, to using her own powerful vocal chords to discuss sound waves — with a Tom Lehrer-like madcap humor and charm. (On the night I attended, an attempt to percussively improvise with crystal wine glasses and bottle blowing devolved into giggles with her piano accompanist and music director Erika Switzer.) Set to music by composers Matthew Schickele, Renée Favand-See, Stefan Weisman, and Conrad Cummings, explanations of the formation of the universe and when humans finally came along are given opera's musical gravitas.
Chinn opens with a quote from Marie Curie — "I am among those who think that science has great beauty" — and her enthusiasm for her subject propels the show. (And if anything flies by your head amid the music, live experiments, and singing, you can find the full libretto online.) The scientific facts and theories are mostly things you might have learned (and later forgotten) in middle and high school, like the structure of atoms and orbital gravity, but without a solid theme linking each through the show it can be hard as a listener to so quickly mentally shift from one topic to the next. However, Science Fair ends gracefully with Chinn wearing a hat that positions a small moon against a light, representing the sun. As she turns, a camera records her perspective, which represents the phases of the moon that we see from Earth. "Have you noticed that half the moon is always bright?," she intones. "The phases of the moon are only what we see / From our place in this orbital geometry." Maybe you won't leave with those school memories retrieved, but Science Fair is more about inspiring curiosity through whatever medium one has available, which for Chinn means the unrivaled drama of opera.
Science Fair: An Opera With Experiments continues through April 24 at HERE Arts Center (145 Sixth Avenue, Soho, Manhattan).


text:
Support LSA
Camp Davis
EARTH Portal
Keyword Search of earth
Apply for Fall Preview
MS Requirements
GeoClub
Graduate Student Publications
Resources for Graduate Students
Field Research Safety Plan Form
Major in Earth and Environmental Sciences
ULWR
Fifth-Year MS
Lecture Fund Established in Honor of Professor Rob Van der Voo
Distinguished Alumni Award
Provide Employment or Internship
Emeritus and Former Alumni Board Members
Update Your Alumni Profile
Earth Camp
Michigan Mineral Alliance
Community Collaboration
Coastal Ocean Environment Summer School in Ghana
Rock and Mineral Identification
Resume and Interview Resources
Jamie Gleason and IODP Expedition 354
EARTH eNews Archive
JOIDES Resolution Recovers 1.7 Kilometers of Drill Core
During February and March of 2015, Jamie Gleason (Associate Research Scientist) participated as a shipboard inorganic geochemist on Expedition 354 of the International Ocean Discovery Program (IODP), which drilled a 7-site E-W transect at ~8°N across the Bay of Bengal (northern Indian Ocean). The goals of the 8-week cruise (Singapore to Colombo, Sri Lanka) were to 1) recover a long-term record of submarine fan sedimentation from the middle Bengal Fan, and 2) capture details of the erosional, uplift and weathering history of the evolving Himalayan Orogen and its impact on global and monsoonal climate. 17 years in the making, Expedition 354 focused on answering several related and long-standing questions regarding 1) long-term carbon storage in tectonically active remnant ocean basins, 2) models for submarine fan migration, evolution, and hydrocarbon potential, 3) tectonic uplift history of the Himalayas and timing of India-Asia collision, and 4) Late Cenozoic interplay between mountain building and the Indian monsoon cycle. The scientific goals of Expedition 354 were designed to overlap with those of Expedition 353 (Indian Monsoon) and the recently concluded Expedition 355 (Arabian Sea), maximizing the scientific payoff of these time- and cost-intensive expeditions [http://iodp.tamu.edu/scienceops/expeditions/bengal_fan.html].
The drill ship used for Expedition 354 was the JOIDES Resolution ("JR" for short), which is leased to the US National Science Foundation and IODP for scientific investigation and sample return from the world's ocean basins [click here for video with sound: https://www.youtube.com/watch?v=pJ_9Vnc0y8c]. Science operations are coordinated through Texas A&M University, which provides the onshore and offshore technical staff and instrumentation to carry out a wide variety of scientific research aboard the JR. Altogether, the ship accommodates over 100 people, with about half being the ship's crew (including drillers, engineers etc.). Technical staff and scientists make up the remainder, with 34 scientists from 14 different countries participating in Expedition 354.
Preliminary research results generated by Expedition 354 have already been published online [http://publications.iodp.org/preliminary_report/354/], even as the on-shore phase of research is just getting underway. Several major findings and surprises were revealed during the course of describing the nearly 1.7 km of core recovered by Expedition 354. These findings are being presented at a host of upcoming international meetings including Goldschmidt (Prague, Czech Republic) and Fall AGU (San Francisco, CA), and include the discovery of 1) an unexpected hiatus in mid-Pleistocene, mid-fan turbidite sedimentation, 2) evidence for high rates of organic carbon burial in the Neogene, 3) downhole termination of fan deposits in the deepest hole drilled, and 4) well-preserved Pleistocene tephra layers from several Toba (Sumatra) ultraplinian volcanic eruptions.
Depth to seafloor in this environment averaged 3.6 kilometers, and the deepest hole we drilled reached 1.2 km below seafloor. Recovery of sediments proved to be a significant challenge, as the loosely consolidated turbidite sands were exceptionally resistant to recovery by conventional drilling and advanced piston coring (APC) operations normally employed on the JR. The solution was to employ a half-length APC (4.5 meter long core barrel) combining drilling without recovery every ~10 meters, a strategy which yielded superior recovery without losing significant drilling time. Primary sedimentary features were beautifully captured this way, an important key to the success of the expedition. Additional strategies were employed on the rig floor/catwalk area to capture loosely consolidated sands from spilling out of the core barrels (especially during our frequent encounters with buried, sand-rich channel deposits).Gleason's IODP-supported post-cruise research will be conducted with colleagues at the University of Arizona's LaserChron Center (ALC) in Tucson, focusing on provenance of the heavy mineral fraction in turbidite sands of Neogene age. Following separation of thousands of individual detrital zircon grains, we will subject them to laser age-dating (U-Pb geochronology) using the mass spectrometers housed in the ALC NSF-supported facility. Our goal is to assemble a record of Himalayan uplift using a variety of provenance tools including zircon single grain U-Pb geochronology, Hf isotope geochemistry and fission track thermochronology, single grain muscovite Ar-Ar thermochronology, and a host of other provenance techniques that will, through our collaborations, utilize nearly all mineral fractions (e.g., quartz, apatite, feldspar, clays and oxides, as well as a complex suite of metamorphic minerals). When the standard 1-year, post-cruise moratorium placed on sample access is lifted, scientists from any institution will be allowed full access to the rich inventory of sediment cores recovered by IODP Expedition 354.
James Gleason
1100 North University Avenue
michigan-earth@umich.edu
LSA News & Events
LSA Dates and Deadlines
LSA Today Newsletter


text:
Q: Solving system if equations containing trigonometric functions with Ti-Nspire In trying to solve the following system of equation:
$20000\times9.81+a\cos b=0$
$a\sin b=6.17\times20000$
Find $a$ and $b$ .
It gives me something containing "n2" in bold and I don't know why?
$a=-231780.07/(-1)^{n2}$
$b=(180*(n2*pi-0.56143476))/pi$
How do I get the right answer? Thanks

A: Try this:
solve(20000*9.81*acos(b)=0 and asin(b)=6.17*20000,a,b)
Answer should yield this:
a=((−123400.)/(cos(3.14*n1))) and b=3.14*(n1-0.5)

A: Compare with standard solution of polar /cartesian  coordinate relations and interpret the differences. Let
$$a/20000= \alpha, 9.81= g;$$
$$ \left(g +\alpha \cos b=0, -6.17+ \alpha \sin b=0 \right)$$
Eliminate b ;
$$ \alpha= \sqrt{g^2+ 6.17^2}; $$
Multiply this by 20000 to get a ;
and
$$ b=\sin^{-1}\dfrac{6.17 }{\alpha}.$$

redpajama_set_name: RedPajamaStackExchange


text:
When homebuilder and developer Granger MacDonald was putting the financing pieces together for a low-income rental housing project in Kerrville, Texas, last year, he was having a hard time trying to make it pencil out.
He truly wanted to make the development work for Kerrville, he recalled in a recent interview, because the city of around 25,000 in the Hill Country about 65 miles north of San Antonio is his hometown.
Courtesy of HUD
However, President Trump's tax reform efforts — some of which MacDonald continues to support — derailed the project: The controversial Tax and Jobs Act of 2017 (which went into effect in 2018) cut the corporate tax rate from 35 percent to 21 percent and made the Low-Income Housing Tax Credit (known as LIHTC and pronounced Lie-Tech) program much less attractive to corporations, decreasing their financial incentive to make equity investments in tax credits. The program encourages investment of private equity in the development of affordable rental housing. Tax credits are issued by the IRS and distributed to housing projects in each state. In 2018, they provided roughly $10 billion in funding for affordable housing.
MacDonald, head of the MacDonald Companies and former chairman of the National Association of Home Builders, campaigned against parts of the tax reform legislation. In late 2017, he wrote:
"The House bill… severely diminishes the effectiveness of the Low-Income Housing Tax Credit, which is essential to spur the production and rehabilitation of affordable rental housing."
"With the nation already in the midst of an affordability crisis, undermining the LIHTC will deal a crippling blow to keep housing affordable and available for those citizens who are most in need."
"We had a project that wasn't very close to making sense financially," said Granger. "And when it lost 5 cents of credit on the dollar (the equivalent of $500,000), it just didn't function anymore. Right now we are seeing the price of tax credits at around 90 cents on the dollar. Prior to the passage of the tax bill, you could get in the high 90s routinely. That makes a substantial difference on a 150-unit project, where you can figure about a 1-cent change will mean about $100,000 less equity."
Courtesy of MacDonald Companies
"I was very disappointed. You really hate having to stop a project, especially when you're doing something like that in your own backyard and it's going to help your own community, because we need workforce housing horribly here in Texas."
According to a recent study by the American Community Survey, the number of renters facing housing cost burdens (i.e. paying more than 30 percent of their income for housing costs) has risen to 21.3 million, which is just about half of all renter households in the nation. Worse, the number of people facing severe cost burdens (devoting more than half their income to housing), has also reached a new record of 11.4 million.
Courtesy of USDA
"We've got a strong demand for jobs with all the growth here in the state, but no place for these folks to live economically, and prices keep going up," MacDonald said.
"Because of the rising costs of materials, land and labor, new market rate (apartment) rents are now close to $1,800 a month to make sense financially. And that's hard for a lot of working people to afford."
"But with the tax credits, you can drop that number down to around $1,100, which is a substantial difference in affordability," said MacDonald, who built his first affordable housing development in 1997 using LIHTC."
"We've always done really well with LIHTC product and we are very proud of it. We own, operate and manage them and have kept most of those we've built."
Photo courtesy of Atlanta Beltline
MacDonald is currently working on another low-income house project that he hopes to build, if he can get the financing through LIHTC and other sources, and another 100-apartment unit development in Bastrop, Texas, on the southeast side of Austin, that was on the ropes because of reductions in corporate taxes, is now going forward.
"We ended up being able to use LIHTC for the Bastrop development and it was very close, but we got it done by finding a secondary source of financing through a private investor. Those units will average $1,000 a month, a real bargain for the Austin market, which is booming."
MacDonald said the tax reform that went into effect last year "certainly forestalled the recession that was right around the corner for this year or next." And that was good. Sunshine (yup, that's his given name) Mathon, head of the Piedmont Housing Alliance in Charlottesville, Va., said the appetite by big companies for LIHTC tax credits began to wane before Trump's inauguration because one of his main platform items was reducing the corporate tax rate to as low as 15 percent.
Still, he said, the primary mechanism for financing affordable housing in the United States remains the LIHTC program.
Courtesy of Reconnecting America
"Roughly 90 percent of affordable housing projects that get built every year in this country uses LIHTC. But that in itself is insufficient to fund affordable housing on its own and requires additional sources. Usually that includes local municipal or county-based fiscal support.
"Depending on the nature of the project, there might also be philanthropic dollars, foundations contributing money or there might be federal home loan bank funds in there. And there is usually some debt as well."
Mathon said there were projects in the preliminary stages of being negotiated all over the country that stalled soon after Trump was elected, "based on the uncertainty of what was going to happen to the tax rate.
Courtesy of Atlanta Beltline
"Many of them had to be renegotiated entirely, or in some cases the projects fell apart because of the uncertainty of what the value of those tax credits was going to be in the long run."
At the time, Mathon was working in Austin, Texas, working for Foundation Communities.
"We saw the value of those tax credits go from roughly $1.10 on the dollar to about 90 cents on the dollar. For us, roughly speaking, every penny difference equated to as much as $150,000 of cash value towards the project's capital stack."
Courtesy Smart Growth America
"Projects in general struggled to make the numbers work for a lot of other reasons, in large part because the cost of construction and land continues to rise. So that drop in tax credit value had a big impact across the industry."
He said the LIHTC program is more than 30 years old and the value of tax credits had dipped in the past, usually when the economy was down. This time it was different, however.
"Generally speaking — because the tax credits were based on supply and demand in the overall market — if you saw a dip in their value, you would usually be in an economic slump. Which nearly always meant the cost of land and construction were also dipping, so it sort of balanced out."
"But this marks the first time in the tax credit program's history that you have the opposite trend. Now you have the value of the credits going down, while the cost of land and materials and labor are going up — which then creates a very difficult gap for projects across the country."
Mathon said when he was leaving Austin, Foundation Communities was designing a 120-unit apartment development community and was in the process of applying for tax credits. The change in tax law, he said, had some significant impacts on the achievability of that project.
"The consequences were that in order to make the project work under the same terms, we had to do a heck of a lot more fundraising and search for more money that was already difficult to find."
"In the end, that project came to fruition after I left because they were able to find additional funding. But you can't do that every time and repeat that over and over. You can only go to the well so often." Currently in Charlottesville, he said the Piedmont Housing Alliance is applying for tax credits for a new, 106-unit apartment development. Rents will range from $400 to $1,200, depending on the different income levels and size of apartments. He said the market-rate rent for a two-bedroom apartment is $1,300.
"The difference in the value of the tax credits we're seeking today, vs. what we believed we could have gotten before is $3 million. That has stretched our need for additional subsidy, considerably. The story is the same all over the country."
"You have individual developers in both nonprofit and for-profit realms who are struggling to figure out how to approach their philanthropic sources. Often times the states that administer tax credit programs have had to scramble to figure out how to help projects and local municipalities are having to stretch their own dollars to bring more resources into developments to make them viable, particularly if they want to incentivize affordability."
Mathon said he'd love to see changes in the tax law, but he has little hope that will happen during the current administration.
"For the most part, everyone I know is working under the assumption that this is the new status quo. Of course, we will advocate for changes in policy. And one great organization that we strongly support is the National Low-Income Housing Coalition, based in D.C. They do extraordinary work around housing issues.
"The president's budget over the past few years has called for very significant cuts in HUD-related funding and other housing-related programs. But each time the president has made certain proposals outside of the tax cut, Congress has soundly and on a bipartisan basis, rejected his proposals.
"In large part, that's because housing is one of those things where almost everyone knows someone who needs access to affordable housing. When you can clarify that position, you have people on both sides who generally support the work that the national providers do."
His only hope, at least in the short term, is that the total number of tax credits offered through LIHTC can be increased.
"That would allow for more affordable housing to be built in general," said Mathon. "And it could also, depending on how the states administered it, permit them to give more tax credits per project to help close the funding gap."
"Because we certainly know the need for affordable housing is not going down. One statistic that the National Low-Housing Coalition recently published is that there is a need in general for about 7 million homes and apartments to fill the affordable housing gap."
Andrew Spofford, chief of staff for the nonprofit Preservation of Affordable Housing (POAH), said there were some concerns during the tax overhaul effort that LIHTC might be done away with entirely.
Courtesy of Richmond Association of REALTORS®
"But there was a big and ultimately successful pushback by housing advocates to retain that tax credit because it is fundamentally the only way we can build affordable housing at any scale in the United States," said Spofford, whose organization owns more than 10,000 affordable apartment developments ranging in size from 27 units to 745 units in the Midwest, Mid-Atlantic, New England and Florida.
"It was a scary process to watch, though, because LIHTC is fundamental to how we advance our mission to house low-income people. If it had been eliminated, it would have been a disaster for anyone who cares about affordable housing from our residents on up."
Fortunately, he said, LIHTC remained. But because corporate tax rates were lowered significantly, the tax credits' value declined.
"The equity that it generates for affordable housing projects is now lower by about 10 percent. So tax reform has had a substantial impact on what we do."
Spofford said the tax credit equity on POAH developments — depending on the specific kind of project — can be from 30 to 70 percent of the budget.
"A reduction of 10 percent can put a hole of $1 million in a project's budget. So you have to go out and try to find $1 million in 'soft money' from state or local governments — money which is already in short supply — to make a project that would have worked in 2015 go forward."
"That means fewer projects are getting built. And the ones that are getting done take longer because you have to go through competitive funding rounds with state and local sources."
"We had projects that were nearing closing and were far along in the financing process when the tax rates changed. Those projects ultimately did go ahead, but they were frozen while we assembled new sources to fill the gaps that resulted. In some cases, POAH put its own money in so a project could go forward because there were residents waiting for renovation or replacement units."
At the same time, Spofford said the need for affordable housing is rising rapidly around the country, with no state or county exempt.
"So the more the need expands and the resources stay the same, it takes longer for any individual project to be funded and proceed. It's nationwide and it's getting worse."
Even though the economy is growing and the national unemployment rate was less than 4 percent in March, Spofford said stagnated wages since the 1970s has made finding affordable housing difficult for many.
"Even with the economy ticking now, I'm not sure if that will change things much," he said. "There is a lot of catching up to do. In some markets, we've heard anecdotally that the improved job market has started to help people — especially where higher minimum wage laws have been passed and are lifting up incomes at the lower end of the wage scale. It's just a start, because wage stagnation is a long-term trend that will take substantial wage gains to offset."
Government agencies haven't created new public housing projects since the early 1980s and most housing production has shifted to a public/private partnership model, he said.
"That's the prevailing model now, where private developers do the development work and public sector agencies to a greater or lesser extent help pay for it," he said."
"The new model — with low-income housing tax credits and government-backed debt — has worked pretty well. When those projects get built, they are built as efficiently as possible because there are good incentives to do that. The LIHTC rental stock has among the lowest failure rates of any class of real estate."
"But there isn't enough of it by any measure," he said. "Nationally there is a vast shortage of affordable housing for people who can't afford market-rate housing. And the changes in the new tax law only made things more difficult."


text:
Home News Trump, Putin discuss first meeting, Syria during 'very good call'
Trump, Putin discuss first meeting, Syria during 'very good call'
Donald Trump and Vladimir Putin discussed steps to ease Syria's civil war and a possible first face-to-face meeting, during what the White House described as a "very good call" Tuesday.
The US and Russian leaders spoke by telephone, focusing on the six-year-old Syrian conflict, which has pitched Moscow and Washington into rival camps.
"President Trump and President Putin agreed that the suffering in Syria has gone on for far too long and that all parties must do all they can to end the violence," the White House said.
Trump aides also said "the conversation was a very good one" that included "discussion of safe, or de-escalation, zones" in Syria "to achieve lasting peace for humanitarian and many other reasons."
The White House said the two leaders also spoke about "how best to resolve the very dangerous situation in North Korea."
And the Kremlin added that both men were "in favor" of meeting at a G20 summit in Germany this July.
That meeting is sure to be closely watched in the United States, where Trump has come under sustained criticism over his campaign's ties to Russia and his praise of Putin.
US intelligence agencies believe that Putin approved of a wide-ranging campaign to tilt the 2016 election in Trump's favor, prompting US sanctions imposed by former president Barack Obama.
The FBI is still investigating possible collusion between the campaign and Moscow.
Trump has been muted in his criticism, but tensions between the White House and the Kremlin have resurfaced after the suspected use of the chemical agent sarin against civilians prompted Trump to strike a Syrian regime airbase also used by Russia.
Secretary of State Rex Tillerson said the call — which he sat in on — was "very productive" with "a lot of detailed exchanges."
"We'll see where we go from here."
No details were given about the possible safe zones, which have long been discussed, but faltered as Bashar al-Assad's regime and assorted groups of rebels, Kurds, Iranian-backed militias, Al-Qaeda and Islamic State fighters have kept-up a bloody war that has killed an estimated half million people.
The Kremlin, meanwhile, said "the emphasis was put on the potential for coordination of actions by the United States and Russia in the fight against terrorism."
The State Department earlier announced that it would send a junior minister to Russian-backed peace talks in Astana later this week.


Our office is known to be one of the most technologically advanced offices in dentistry. 3D dentistry has been around over 20 years, but it's the last few years that it's just taken leaps and bounds in technology. Give you an example, I can scan a person's mouth both with x-rays and visually, and I'll want an implant placed at a certain location. He can marriage and merge that image into his 3D scan of the patient's jaw and we can design the position and placement of that implant before the surgery's ever done.


In the '70s, everyone knew who David Cassidy was. He was the lead singer of The Partridge Family and was a veritable heartthrob.
But according to Jo-Ann Geffen, his publicist, he died at the age of 67.
Just recently the famous actor-singer was at the ICU of a hospital in Fort Lauderdale, Florida.
He was already in critical condition and his organs were already failing him. Then on Tuesday, he passed away.
The well-known Cassidy died surrounded by the people he loved the most. He was happy and was finally free from the pain and suffering.
His family extends their gratitude for the support and abundance shown to Cassidy throughout the years. His nephew even tweeted about the celebrity.
He thanked God for the joy Cassidy brought to the people. Despite all the ups and downs of his life, he still left a mark on all the fans, friends, and loved ones he left behind.
Pink slammed the people who said negative nonsense about her. They claimed that she "grimaced" during Christina Aguilera's performance at the American Music Awards.
Christina sang a medley as a tribute to the late Whitney Houston at the awards ceremony. That night, an image of Pink went viral with claims that she wasn't feeling Christina's performance.
However, she quickly shut down those accusations. She even said that Christina actually "killed it" and she remains in awe of the singer's talent. Although Pink and Christina had feuds in the past, they've already made amends.
Pink even tweeted early this year that they've already moved on.
Despite the controversial photo of Pink, Christina's performance at the AMAs received a standing ovation.
In fact, while she was singing, a lot of the audience members sang along to the chart-topping songs taken from The Bodyguard soundtrack. Pink, along with everyone else, agrees that Christina crushed her performance.
Selena Gomez is a rising pop star in Hollywood. However, some people believe that Selena Gomez's performance at the 2017 AMAs fell flat.
It was quite a feat for the pop start to start performing even after receiving a new kidney a few months earlier. However, viewers at home were very disappointed as they claimed that she lip-synced her whole "Wolves" performance.
E! News tried reaching out to Selena's rep for any comment. But until now, the singer has yet to publicly address those comments.
Selena, 25, came up on stage dressed in slinky lingerie and a blond hairstyle. DJ Marshmello joined her on stage along with a group of professional dancers.
Of course, the reactions were, as expected, mixed. Some fans applauded Selena for her performance despite her recent medical procedure.
While others felt let down because of her alleged lip syncing. Both groups weren't shy to share their comments on different social media platforms such as Twitter.
On Friday Ms. Perry and her legal team could celebrate in style. $1,6 million in damages and a further $10 million may be awarded in punitive damages.
Perry, and the Archdiocese of LA, sued Hollister, a businesswoman and restauranteur, who tried to prevent Perry purchasing her dream property, an abandoned convent overlooking LA.
The sale of the 8-acre property was hotly contested, and while the Immaculate Heart nuns may not approve of Ms. Perry's music videos or confident sexuality, they were quite keen on Hollister, whose offer included a substantial sum paid, to the nuns.
They did not seem to mind Ms. Hollister's plans to build a boutique hotel, restaurant, and bar.
The Roman Catholic Archbishop of Los Angeles was awarded $3,5 million in damages. Thou shall not try to fraudulently thwart Ms. Perry, or you will hear her roar. Aplenty. You have been warned.


Telstra chairman John Mullen has acknowledged that the end of Telstra's policy to pay almost all profits out as dividends is tough on shareholders but said he expects the company to maintain or increase the total dividend over time as earnings grow.
"Changing the dividend policy was one of the toughest decisions the board has ever had to make," Mr Mullen told shareholders at the company's annual general meeting in Melbourne.
"We spent many long hours debating it, many sleepless nights working it through in our minds, knowing full well the impact it would have on our shareholders."
The telco is seeing $3 billion of earnings taken away because of the NBN which is replacing Telstra as the monopoly wholesale provider.
In August it announced it would pay out between 70 and 90 per cent of earnings from fiscal 2018, rather than close to 100 per cent.
It was the first big change in dividend policy since the telco was floated by the government in 1997 and means shareholders will wear a 30 per cent cut in the total dividend to 22¢ a share next year.
Mr Mullen said the company would not acquire businesses to replace the lost earnings as this would be too risky.
"And to expect that we can suddenly just go out and create another $3 billion EBITDA business overnight is simply just not realistic," he said.
The dividend policy shift was "one change among many" that Telstra needed to make. "We absolutely understand and empathise with your [shareholder] concerns over the dividend," he said.
"Whether we like it or not, we have to accept the world around us has changed dramatically and Telstra is having to change just as dramatically as well."
Mr Mullen noted that the big tech giants like Amazon did not pay out dividends, because they reinvested to grow market share and reduce prices and enhance product offerings. That drove enormous share price appreciation.
He said Telstra was not about to completely ditch handing out dividends to its shareholders - in addition to the ordinary reduced dividend, Telstra intends to return around 75 per cent of net one-off NBN receipts over time through special dividends.
Australia was a yield-driven market with high payout ratios, he said. "We would never consider not paying a dividend ... but if one hadn't and had behaved the same way as some of those other companies we would have a war chest of $50 billion."
Mr Mullen also defended concerns over remuneration including Telstra chief executive Andrew Penn's pay. Mr Penn earned $2.3 million in fixed pay, a $1.49 million bonus and $1.04 million in shares, bringing his take-home pay to $5.21 million.
Angry shareholders at the meeting expressed concerns over the total package, which they viewed as excessive.
"I can assure you that the remuneration committee and board take remuneration extremely seriously," Mr Mullen said.
"We're constantly mindful of the balance between attracting the best talent but also meeting shareholder concerns and expectations over the long-term."
Mr Mullen also spoke of Telstra's new "formidable" competitor TPG, which is spending almost $2 billion to build Australia's fourth mobile network.
"We do not underestimate the impact this may have, the effect on pricing, nor the fact that we must – and most certainly will – continue to invest heavily to maintain our mobile network superiority and continue to improve the experience we offer our customers," Mr Mullen said.
Mr Penn also addressed shareholders, saying increased competition, digital disruption and the migration to the NBN would create a tough operating environment over the next two to three years.
He said the move to connect 4 million homes under the NBN needed to be faster and pricing needed to be more affordable.
Consumer complaints about poor speeds have been on the rise, with some users reporting NBN is worse than previous DSL connections.
Mr Penn said wholesale broadband prices in Australia from NBN are increasing by almost 100 per cent in the migration.
"This will increase by a further 20 to 25 per cent over the next three-four years under NBN's plans," he said.
Mr Penn also spoke of the company's longer-term strategic direction, including Telstra's move to be a technology company rather than a traditional telco.
Telstra was building new skills in areas including software engineering, data science, AI and in quantum computing, he said.
Telcos had been investing tens of billions of dollars so customers can stream services such as Netflix, which was now valued at more than $US87 billion, but this value had not been captured by companies like Telstra, he said.
"That's why our vision is to become a world-class technology company that empowers people to connect," Mr Penn said.
The company booked a reduced full-year profit of $3.89 billion, compared with $5.85 billion the year before.
Telstra also confirmed its guidance for 2017-18. It expects income in the range of $28.3 billion to $30.2 billion and earnings before interest, tax, depreciation and amortisation (EBITDA) of $10.7 billion to $11.2 billion.
Telstra's share price closed flat at $3.55 on Tuesday.


The Pharmaceutical Reagents Institute Repharm Ltd.
programmer 14:39 The Pharmaceutical Reagents Institute Repharm Ltd.
The medical cosmetics Repharm contain Bisphosphonate, an active natural substance, which manages the calcium homeostasis, rids the body of excess salt, supports joint strength, provides the motor system mobility and maintains elastic, fresh and smoothen skin.
Using Repharm cosmetics is the way to the healthy wellbeing from young till old age. Our natural cosmetics make you act and feel better, provide healthy appearance and adolescence.


Description: A hunter, dog and pheasant silhouette the top of this reversible double light switch plate cover. Can be installed facing either direction. Laser cut with extraordinary detail and quality. Mounting hardware included.


Discussion in 'iOS Questions' started by Albi, May 10, 2015.
B4i Question [Solved] CLV.AddTextItem how to reduce the height ?
I have a custom list view and when I select one of the items, it goes to page5 with a customListView (clv3a).
However, when it is created, if it is larger than the previous text that was the there, the label height is the same height as it was previously. If I go back and into it again, it is now the right height.
It still scrolls fine, so the content height is set ok.
I took logs of the label height and contentheight within the custom class and they matched up, both when it was the 'wrong' height and the right height!
I tried adding this to the bottom of the code above hoping that would fix it but it did not.
i'd rather not upload the whole project as i'm making it for someone else, but obv will if it's really necessary!
Please try to create a minimal example and upload it.
if you go to the third tab (it's a tableview), and choose the 1st option, the clv text will be the right size. then if you go back and choose 2nd or 3rd option, you'll see the clv text is the wrong size (but it scrolls nicely!). Go back and then into the same option, and it will be the perfect size.
was where i tried to adjust the left to 10 and have the width as 100%x-20 but then it didn't fit in the page horizontally.
The problem is that %x and %y are only guaranteed to be correct in Page_Resize event. I think you should split it into several classes (or modules) to make it more organized.
Instead of using %x and %y you can use the current page size (not page 5).
thanks for the reply, that worked nicely.
and i do need to work on coding organization (lack of) skills!


text:
/* See cxx source for full Copyright notice */
/* $Id$ */
#ifndef AliMCTrackInfoContainer_H
#define AliMCTrackInfoContainer_H

#include "TClonesArray.h"

#include "AliPIDResponse.h"
#include "AliMCEvent.h"
#include "AliAODTrack.h"
#include "AliAODMCParticle.h"
#include "AliESDtrack.h"
#include "AliESDEvent.h"
#include "AliESDtrackCuts.h"

class AliMCTrackInfoContainer : public TObject
{
public:
    AliMCTrackInfoContainer(); // default constructor
    AliMCTrackInfoContainer(const AliMCTrackInfoContainer &source); // copy constructor
    virtual ~AliMCTrackInfoContainer();//destructor.

    void Fill(const AliAODTrack* primTrack, const AliPIDResponse* fPIDResponse, Double_t lBestPrimaryVtxPos[3], Double_t lMagField, const AliMCEvent* lMCEvent);
    void Reset();

    void Copy(AliMCTrackInfoContainer *source);

    Float_t GetLengthInActiveZone(const AliAODTrack *gt, Float_t deltaY, Float_t deltaZ, Float_t b );
    Float_t GetDCAz(AliAODTrack *lTrack);

    Bool_t  CheckITSClusterRequirement(AliESDtrackCuts::ITSClusterRequirement req, Bool_t clusterL1, Bool_t clusterL2);

    Bool_t IsSelected( const AliESDtrackCuts* lPrimTrackCuts );
    //setter
    void SetPassesTrackCuts2010         (Bool_t value) { fTreePrimVarPassesTrackCuts2010            = value ;}
    void SetPassesTrackCuts2011         (Bool_t value) { fTreePrimVarPassesTrackCuts2011            = value ;}
    void SetPassesTrackCutsTPCRefit     (Bool_t value) { fTreePrimVarPassesTrackCutsTPCRefit        = value ;}
    void SetPassesTrackCuts2011Sys      (Bool_t value) { fTreePrimVarPassesTrackCuts2011Sys         = value ;}
    void SetPassesTrackCutsV0           (Bool_t value) { fTreePrimVarPassesTrackCutsV0              = value ;}
    void SetPassesTrackCutsHybrid_kOff  (Bool_t value) { fTreePrimVarPassesTrackCutsHybrid_kOff     = value ;}
    void SetPassesTrackCutsHybrid_kNone (Bool_t value) { fTreePrimVarPassesTrackCutsHybrid_kNone    = value ;}

    //getter
    //-----------BASIC-INFO---------------------------
    Int_t GetCharge                             () const { return  fTreePrimVarCharge    ;}
    Double_t GetRapPion                         () const { return  fTreePrimVarRapPion    ;}
    Double_t GetRapProton                       () const { return  fTreePrimVarRapProton    ;}
    Double_t GetRapKaon                         () const { return  fTreePrimVarRapKaon    ;}
    Double_t GetEta                             () const { return  fTreePrimVarEta    ;}
    Double_t GetPtot                            () const { return  fTreePrimVarPtot    ;}
    Double_t GetPt                              () const { return  fTreePrimVarPt    ;}

    Double_t GetDCAxyToPV                       () const { return  fTreePrimVarDCAxyToPV    ;}
    Double_t GetDCAzToPV                        () const { return  fTreePrimVarDCAzToPV    ;}

    Int_t GetNbrCrossedRows                     () const { return  fTreePrimVarNbrCrossedRows    ;}
    Double_t GetRatioCrossedRowsOverFindable    () const { return  fTreePrimVarRatioCrossedRowsOverFindable    ;}
    Int_t GetITSNbrClusters                     () const { return  fTreePrimVarITSNbrClusters    ;}
    Int_t GetTPCNbrClusters                     () const { return  fTreePrimVarTPCNbrClusters    ;}
    Double_t GetNbrCrossedRowsOverLength        () const { return  fTreePrimVarNbrCrossedRowsOverLength    ;}
    Double_t GetFractionSharedTPCClusters       () const { return  fTreePrimVarFractionSharedTPCClusters    ;}
    Double_t GetChi2perNDF                      () const { return  fTreePrimVarChi2perNDF; }
    Double_t GetITSChi2PerCluster               () const { return  fTreePrimVarITSChi2PerCluster    ;}
    Double_t GetTPCChi2PerCluster               () const { return  fTreePrimVarTPCChi2PerCluster    ;}
    Double_t GetChi2TPCConstainedVsGlobal       () const { return  fTreePrimVarChi2TPCConstrainedVsGlobal;}
    Double_t GetTrackLength                     () const { return  fTreePrimVarTrackLength    ;}
    //---------------PID-TPC-INFO---------------------
    Float_t GetNSigmaPion                       () const { return  fTreePrimVarNSigmaPion    ;}
    Float_t GetNSigmaKaon                       () const { return  fTreePrimVarNSigmaKaon    ;}
    Float_t GetNSigmaProton                     () const { return  fTreePrimVarNSigmaKaon    ;}
    //---------------PID-TOF-INFO---------------------
    Float_t GetTOFNSigmaPion                    () const { return  fTreePrimVarTOFNSigmaPion    ;}
    Float_t GetTOFNSigmaKaon                    () const { return  fTreePrimVarTOFNSigmaKaon    ;}
    Float_t GetTOFNSigmaProton                  () const { return  fTreePrimVarTOFNSigmaProton    ;}
    //---------------PID-ITS-INFO---------------------
    Float_t GetITSNSigmaPion                    () const { return  fTreePrimVarITSNSigmaPion    ;}
    Float_t GetITSNSigmaKaon                    () const { return  fTreePrimVarITSNSigmaKaon    ;}
    Float_t GetITSNSigmaProton                  () const { return  fTreePrimVarITSNSigmaProton    ;}
    //---Raw TPC dEdx + PIDForTracking information----
    Double_t GetdEdx                            () const { return  fTreePrimVardEdx    ;}
    Double_t GetdEdxN                           () const { return  fTreePrimVardEdxN    ;}
    Double_t GetPIDForTracking                  () const { return  fTreePrimVarPIDForTracking    ;}
    //------------------------------------------------
    ULong64_t GetTrackStatus                    () const { return  fTreePrimVarTrackStatus    ;}
    UInt_t GetFilterMap                    		() const { return  fTreePrimVarFilterMap    ;}
    //------------------------------------------------
    Int_t GetLabel                              () const { return  fTreePrimVarLabel    ;}
    //------------FULL-MOMENTUM-INFO------------------
    Double_t GetPx                              () const { return  fTreePrimVarPx    ;}
    Double_t GetPy                              () const { return  fTreePrimVarPy    ;}
    Double_t GetPz                              () const { return  fTreePrimVarPz    ;}
    //---------------CLUSTER-INFO---------------------
    Bool_t GetITSClusters0                      () const { return  fTreePrimVarITSClusters0    ;}
    Bool_t GetITSClusters1                      () const { return  fTreePrimVarITSClusters1    ;}
    Bool_t GetITSClusters2                      () const { return  fTreePrimVarITSClusters2    ;}
    Bool_t GetITSClusters3                      () const { return  fTreePrimVarITSClusters3    ;}
    Bool_t GetITSClusters4                      () const { return  fTreePrimVarITSClusters4    ;}
    Bool_t GetITSClusters5                      () const { return  fTreePrimVarITSClusters5    ;}
    //------------------------------------------------
    Bool_t GetITSSharedClusters0                () const { return  fTreePrimVarITSSharedClusters0    ;}
    Bool_t GetITSSharedClusters1                () const { return  fTreePrimVarITSSharedClusters1    ;}
    Bool_t GetITSSharedClusters2                () const { return  fTreePrimVarITSSharedClusters2    ;}
    Bool_t GetITSSharedClusters3                () const { return  fTreePrimVarITSSharedClusters3    ;}
    Bool_t GetITSSharedClusters4                () const { return  fTreePrimVarITSSharedClusters4    ;}
    Bool_t GetITSSharedClusters5                () const { return  fTreePrimVarITSSharedClusters5    ;}

    //---------------OOB-PILEUP-INFO---------------------
    Double_t GetTOFExpTDiff                     () const { return  fTreePrimVarTOFExpTDiff    ;}
    Double_t GetTOFSignal                       () const { return  fTreePrimVarTOFSignal    ;}
    Int_t   GetTOFBCid                          () const { return  fTreePrimVarTOFBCid    ;}

    Double_t GetTOFLength                       () const { return  fTreePrimVarTOFLength    ;}
    Double_t GetTOFDeltaX                       () const { return  fTreePrimVarTOFDeltaX    ;}
    Double_t GetTOFDeltaZ                       () const { return  fTreePrimVarTOFDeltaZ    ;}

    //Kink tagging
    Bool_t GetIsKink                            () const { return  fTreePrimVarIsKink    ;}

    //------------TRACK-CUTS-CHECK------------------
    Bool_t GetPassesTrackCuts2010               () const { return  fTreePrimVarPassesTrackCuts2010;}
    Bool_t GetPassesTrackCuts2011               () const { return  fTreePrimVarPassesTrackCuts2011;}
    Bool_t GetPassesTrackCutsTPCRefit           () const { return  fTreePrimVarPassesTrackCutsTPCRefit;}
    Bool_t GetPassesTrackCuts2011Sys            () const { return  fTreePrimVarPassesTrackCuts2011Sys;}
    Bool_t GetPassesTrackCutsV0                 () const { return  fTreePrimVarPassesTrackCutsV0;}
    Bool_t GetPassesTrackCutsHybrid_kOff        () const { return  fTreePrimVarPassesTrackCutsHybrid_kOff;}
    Bool_t GetPassesTrackCutsHybrid_kNone       () const { return  fTreePrimVarPassesTrackCutsHybrid_kNone ;}

    Double_t GetPositionX                       () const { return  fTreePrimVarPosX     ;}
    Double_t GetPositionY                       () const { return  fTreePrimVarPosY     ;}
    Double_t GetPositionZ                       () const { return  fTreePrimVarPosZ     ;}

    //------------MONTE-CARLO-INFO------------------
    Int_t GetPdgCode                            () const { return  fTreePrimVarPdgCode    ;}
    Double_t GetMassMC                          () const { return  fTreePrimVarMassMC    ;}
    Double_t GetRapMC                           () const { return  fTreePrimVarRapMC    ;}
    Double_t GetEtaMC                           () const { return  fTreePrimVarEtaMC    ;}
    Double_t GetPtotMC                          () const { return  fTreePrimVarPtotMC    ;}
    Double_t GetPtMC                            () const { return  fTreePrimVarPtMC    ;}
    Double_t GetPxMC                            () const { return  fTreePrimVarPxMC    ;}
    Double_t GetPyMC                            () const { return  fTreePrimVarPyMC    ;}
    Double_t GetPzMC                            () const { return  fTreePrimVarPzMC    ;}

    Int_t GetMotherPdgCode                      () const { return  fTreePrimVarMotherPdgCode                    ;}
    Int_t GetGrandMotherPdgCode                 () const { return  fTreePrimVarGrandMotherPdgCode               ;}
    Int_t GetMotherLabel                        () const { return  fTreePrimVarMotherLabel                      ;}
    Int_t GetGrandMotherLabel                   () const { return  fTreePrimVarGrandMotherLabel                 ;}

    Bool_t GetIsPhysicalPrimary                 () const { return  fTreePrimVarIsPhysicalPrimary                ;}
    Bool_t GetIsPhysicalPrimaryMother           () const { return  fTreePrimVarIsPhysicalPrimaryMother          ;}
    Bool_t GetIsPhysicalPrimaryGrandMother      () const { return  fTreePrimVarIsPhysicalPrimaryGrandMother     ;}

private:
    //===========================================================================================
    //   Variables for Primary tracks Tree
    //===========================================================================================
    //-----------BASIC-INFO---------------------------
    Int_t fTreePrimVarCharge; //
    Double_t fTreePrimVarRapPion; //
    Double_t fTreePrimVarRapProton; //
    Double_t fTreePrimVarRapKaon; //
    Double_t fTreePrimVarEta; //
    Double_t fTreePrimVarPtot; //
    Double_t fTreePrimVarPt; //

    Double_t fTreePrimVarDCAxyToPV;//
    Double_t fTreePrimVarDCAzToPV;//

    Int_t fTreePrimVarNbrCrossedRows;//
    Double_t fTreePrimVarRatioCrossedRowsOverFindable;//
    Int_t fTreePrimVarITSNbrClusters;//
    Int_t fTreePrimVarTPCNbrClusters;//
    Double_t fTreePrimVarNbrCrossedRowsOverLength;//
    Double_t fTreePrimVarFractionSharedTPCClusters;//
    Double_t fTreePrimVarChi2perNDF;//          Max track chi2
    Double_t fTreePrimVarITSChi2PerCluster;//
    Double_t fTreePrimVarTPCChi2PerCluster;//
    Double_t fTreePrimVarChi2TPCConstrainedVsGlobal;//
    Double_t fTreePrimVarTrackLength;  //
    //---------------PID-TPC-INFO---------------------
    Float_t fTreePrimVarNSigmaPion;//
    Float_t fTreePrimVarNSigmaKaon;//
    Float_t fTreePrimVarNSigmaProton;//
    //---------------PID-TOF-INFO---------------------
    Float_t fTreePrimVarTOFNSigmaPion;//
    Float_t fTreePrimVarTOFNSigmaKaon;//
    Float_t fTreePrimVarTOFNSigmaProton;//
    //---------------PID-ITS-INFO---------------------
    Float_t fTreePrimVarITSNSigmaPion;//
    Float_t fTreePrimVarITSNSigmaKaon;//
    Float_t fTreePrimVarITSNSigmaProton;//
    //---Raw TPC dEdx + PIDForTracking information----
    Double_t fTreePrimVardEdx;//
    Double_t fTreePrimVardEdxN;//
    Double_t fTreePrimVarPIDForTracking;//
    //------------------------------------------------
    ULong64_t fTreePrimVarTrackStatus;//
    UInt_t fTreePrimVarFilterMap;//
    //------------------------------------------------
    Int_t fTreePrimVarLabel;//
    //------------FULL-MOMENTUM-INFO------------------
    Double_t fTreePrimVarPx; //
    Double_t fTreePrimVarPy; //
    Double_t fTreePrimVarPz; //
    //---------------CLUSTER-INFO---------------------
    Bool_t fTreePrimVarITSClusters0;//
    Bool_t fTreePrimVarITSClusters1;//
    Bool_t fTreePrimVarITSClusters2;//
    Bool_t fTreePrimVarITSClusters3;//
    Bool_t fTreePrimVarITSClusters4;//
    Bool_t fTreePrimVarITSClusters5;//
    //------------------------------------------------
    Bool_t fTreePrimVarITSSharedClusters0;//
    Bool_t fTreePrimVarITSSharedClusters1;//
    Bool_t fTreePrimVarITSSharedClusters2;//
    Bool_t fTreePrimVarITSSharedClusters3;//
    Bool_t fTreePrimVarITSSharedClusters4;//
    Bool_t fTreePrimVarITSSharedClusters5;//

    //---------------OOB-PILEUP-INFO---------------------
    Double_t fTreePrimVarTOFExpTDiff; //
    Double_t fTreePrimVarTOFSignal; //
    Int_t   fTreePrimVarTOFBCid; //

    Double_t fTreePrimVarTOFLength;//
    Double_t fTreePrimVarTOFDeltaX;//
    Double_t fTreePrimVarTOFDeltaZ;//

    //Kink tagging
    Bool_t fTreePrimVarIsKink;//

    //------------TRACK-CUTS-CHECK------------------
    Bool_t fTreePrimVarPassesTrackCuts2010;//
    Bool_t fTreePrimVarPassesTrackCuts2011;//
    Bool_t fTreePrimVarPassesTrackCutsTPCRefit;//
    Bool_t fTreePrimVarPassesTrackCuts2011Sys;//
    Bool_t fTreePrimVarPassesTrackCutsV0;//
    Bool_t fTreePrimVarPassesTrackCutsHybrid_kOff;//
    Bool_t fTreePrimVarPassesTrackCutsHybrid_kNone;//

    Double_t fTreePrimVarPosX;//
    Double_t fTreePrimVarPosY;//
    Double_t fTreePrimVarPosZ;//

    //------------MONTE-CARLO-INFO------------------
    Int_t fTreePrimVarPdgCode;//
    Double_t fTreePrimVarMassMC;//
    Double_t fTreePrimVarRapMC;//
    Double_t fTreePrimVarEtaMC;//
    Double_t fTreePrimVarPtotMC;//
    Double_t fTreePrimVarPtMC;//
    Double_t fTreePrimVarPxMC;//
    Double_t fTreePrimVarPyMC;//
    Double_t fTreePrimVarPzMC;//

    Int_t fTreePrimVarMotherPdgCode;//
    Int_t fTreePrimVarGrandMotherPdgCode;//
    Int_t fTreePrimVarMotherLabel;//
    Int_t fTreePrimVarGrandMotherLabel;//

    Bool_t fTreePrimVarIsPhysicalPrimary;//
    Bool_t fTreePrimVarIsPhysicalPrimaryMother;//
    Bool_t fTreePrimVarIsPhysicalPrimaryGrandMother;//

    //------------------------------------------------
    ClassDef(AliMCTrackInfoContainer, 1);
};
#endif

redpajama_set_name: RedPajamaGithub


text:
Paul Rejczak
Writer, Sunshine Profits
Stock market strategist, who has been known for quality of his technical and fundamental analysis since the late nineties. He is interested in forecasting market…
Stock Trading Alert: SP500 Index Back At 2,100 Mark, Will It Continue Higher?
By Paul Rejczak - Jul 05, 2016, 1:18 PM CDT
Stock Trading Alert originally published on July 5, 2016, 6:58 AM:
Briefly: In our opinion, speculative short positions are favored (with stop-loss at 2,140, and profit target at 2,100, S&P 500 index).
Our intraday outlook is now bearish, and our short-term outlook is bearish. Our medium-term outlook remains bearish, as the S&P 500 index extends its lower highs, lower lows sequence:
Intraday outlook (next 24 hours): bearish
Short-term outlook (next 1-2 weeks): bearish
Medium-term outlook (next 1-3 months): bearish
Long-term outlook (next year): neutral
The main U.S. stock market indexes gained 0.1-0.5% on Friday, extending their short-term uptrend, as investors reacted to economic data releases, among others. The S&P 500 index broke slightly above the level of 2,100, as it retraced its "Brexit" selloff. The nearest important level of resistance is at 2,110-2,120, marked by last month's local highs. The next resistance level is at around 2,130-2,135, marked by last year's all-time high of 2,134.72. On the other hand, support level is at around 2,080-2,085, marked by previous level of resistance, and the next level of support is at 2,050-2,070. Last year's highs along the level of 2,100 continue to act as medium-term resistance level. Is this some long-term topping pattern or just medium-term consolidation following a rebound off February low?
Expectations before the opening of today's trading session are negative, with index futures currently down 0.4-0.5%. The European stock market indexes have been mixed so far. Investors will now wait for the Factory Orders number release at 10:00 a.m. The S&P 500 futures contract trades within an intraday downtrend, as it retraces some of its recent advance. The nearest important level of support is at around 2,080. On the other hand, resistance level is at 2,090-2,095, marked by an intraday local high, as we can see on the 15-minute chart:
The technology Nasdaq 100 futures contract follows a similar path, as it currently trades closer to the level of 4,400. It retraces some of its last week's rally. The nearest important level of support remains at 4,400, and resistance level is at 4,430, marked by an intraday local high, as the 15-minute chart shows:
Concluding, the broad stock market extended its rally on Friday, as the S&P 500 index retraced its "Brexit" selloff. We can see short-term overbought conditions accompanied by some bearish technical divergences. Therefore, we decided to open a speculative short position at the opening of today's cash market trading session (S&P 500 index). Stop-loss level is at 2,140 and potential profit target is at 2,000 (S&P 500 index). You can trade S&P 500 index using futures contracts (S&P 500 futures contract - SP, E-mini S&P 500 futures contract - ES) or an ETF like the SPDR S&P 500 ETF - SPY. It is always important to set some exit price level in case some events cause the price to move in the unlikely direction. Having safety measures in place helps limit potential losses while letting the gains grow.
NYSE Megaphone Top and Brexit
5-Year Cycle?


text:
Augusta Wilhelmina Malmlöf, känd som Wilma Malmlöf, född Höglund den 17 september 1888 i Söderhamn, död den 31 oktober 1971 i Älvsjö, Brännkyrka församling, Stockholm, var en svensk skådespelare.

Malmlöf filmdebuterade i Manne Göthsons Storstadsfaror 1918, hon kom att medverka i drygt 65 filmproduktioner. Hon var sedan 1916 gift med skådespelaren Eric Malmlöf. De är begravda på Sandsborgskyrkogården i Stockholm.

Filmografi i urval

Teater

Roller

Källor

Fotnoter

Externa länkar

Svenska skådespelare under 1900-talet
Svenska scenskådespelare
Svenska stumfilmsskådespelare
Personer från Söderhamn
Gravsatta på Sandsborgskyrkogården
Födda 1888
Avlidna 1971
Kvinnor

redpajama_set_name: RedPajamaWikipedia